DoW Bone Marrow Failure, Idea Development Award
🏛 Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
✓ Free, no account · Source: Grants.gov · Last verified Sep 6, 2026
Can you apply?
This grant is for researchers studying bone marrow failure diseases. Established Investigators and Early-Career Investigators are eligible to apply. Reviewers use separate criteria for each investigator type. Applicants must demonstrate ability to generate interpretable results without preliminary data.
The award supports innovative, evidence-based research ideas aligned with understanding and curing BMF diseases. Researchers must have capacity to conduct the proposed work independently. Academic institutions, research centers, and affiliated organizations are typical applicants.
Not the right fit? Find grants for your organization in 5 questions →
Program description
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases.
Distinctive Features:
This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs). Reviewers will assess Principal Investigators (PIs) using distinct review criteria based on their eligibility as an EI or ECI.
Preliminary data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- Research Proposal/Project Narrative
- Budget and Budget Justification
- Biographical Sketch or CV
- Letters of Support/Institutional Commitment
- Conflict of Interest Disclosure
Program contact
- 👤 Christopher L Baker Grants Officer
- 📧 help@eBRAP.org
- 📞 3016192332
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$77,591,450
-
$74,531,880
-
$55,443,120
-
$34,191,124
-
$24,783,894
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- CA 13 awards $114.4M
- FL 8 awards $99.8M
- MA 8 awards $83.2M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who can apply for this grant?
Established Investigators and Early-Career Investigators can apply. Both groups face distinct review criteria based on career stage.
Is preliminary data required?
No. Applications should show the ability to achieve interpretable results without preliminary data supporting the hypothesis.
What does this grant fund?
Innovative ideas and high-impact research approaches for understanding and curing bone marrow failure diseases.
When is the deadline?
The fixed deadline is November 4, 2026.
What funding mechanisms are available?
Awards are offered as either a Grant or Cooperative Agreement.
💡 Tips for applicants
- Emphasize innovation and impact potential over preliminary data; focus on study design rigor instead.
- Tailor your application to your investigator category (EI vs. ECI) since reviewers use different evaluation criteria.
- Show a clear pathway to interpretable results despite the lack of preliminary data requirement.
- Align your research approach with the BMFRP's vision of understanding and curing bone marrow failure.
- Highlight the scientific soundness of your methodology and feasibility of your proposed approach.
⚠️ Common mistakes
Submitting weak study designs expecting preliminary data will compensate. Ignoring the distinct EI vs. ECI review criteria in your proposal narrative. Proposing research misaligned with bone marrow failure disease focus.
Similar grants
- OPEN DoW Bone Marrow Failure, Investigator-Initiated Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Bone Marrow Failure, Resource Development Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Rare Cancers Idea Development Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Kidney Cancer, Idea Development Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Neurofibromatosis Investigator-Initiated Research Award — Defense Health Agency Contracting Activity - DHACA